about
sameAs
Risk of acute myocardial infarction after transurethral resection of prostate in elderlyThe development of the pediatric NAFLD fibrosis score (PNFS) to predict the presence of advanced fibrosis in children with nonalcoholic fatty liver diseaseAtherogenic dyslipidemia and cardiovascular risk factors in obese childrenMyocardial β(2) -adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure.Myocardial pathology induced by aldosterone is dependent on non-canonical activities of G protein-coupled receptor kinases.Prognostic Value of Lymphocyte G Protein-Coupled Receptor Kinase-2 Protein Levels in Patients With Heart FailureGRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractility.Negative impact of β-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms.Targeting the β-adrenergic receptor system through G-protein-coupled receptor kinase 2: a new paradigm for therapy and prognostic evaluation in heart failure: from bench to bedside.β-adrenergic receptors and G protein-coupled receptor kinase-2 in Alzheimer's disease: a new paradigm for prognosis and therapy?Molecular aspects of the cardioprotective effect of exercise in the elderly.Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapyβ1-adrenergic receptor and sphingosine-1-phosphate receptor 1 (S1PR1) reciprocal downregulation influences cardiac hypertrophic response and progression to heart failure: protective role of S1PR1 cardiac gene therapyImpact of diabetes mellitus on lymphocyte GRK2 protein levels in patients with heart failure.Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure.Differential expression of duplicated genes for prothymosin alpha during zebrafish development.Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.β Adrenergic Receptor Kinase C-Terminal Peptide Gene-Therapy Improves β2-Adrenergic Receptor-Dependent Neoangiogenesis after Hindlimb Ischemia.Vascular endothelial growth factor blockade prevents the beneficial effects of β-blocker therapy on cardiac function, angiogenesis, and remodeling in heart failure.Prothymosin alpha protects cardiomyocytes against ischemia-induced apoptosis via preservation of Akt activation.Reduction of lymphocyte G protein-coupled receptor kinase-2 (GRK2) after exercise training predicts survival in patients with heart failure.[From bench to bedside: new insights into the treatment of heart failure]
P50
Q26859700-0DF3AECC-DE7F-4D1E-B305-1D380FA6EB4DQ34046719-BDF81D3E-170D-4344-B0AE-F13E9A3B55CAQ34461856-DF0D031B-4305-44ED-8A0D-48735D7B9106Q36252791-14DD6204-2EF4-4FD9-BC15-1EF10671F966Q36651023-2FB9D01A-4207-4C12-A509-F4D7C349A70CQ36757784-8302B387-46BE-4C04-A28B-02CC629C9C35Q37356016-DDDFBCF9-401B-40E4-960A-EE8148C1FC46Q37470858-1594BB51-151F-4EBA-9C2B-17DCA2477186Q38010421-5D045363-1844-40FF-BF44-635B9BE67E56Q38064688-371E87EB-ADD6-405B-8C7C-B004FD3C2A4EQ38129354-4167A1BC-7F15-4699-89F5-AA51C920E46EQ38153376-8E0136CA-79BC-4084-9CDE-6F81FE2DF0CCQ38266154-CC96858A-F7DF-41FB-8C34-C0DD26D8E092Q41643288-4D0B91A3-63D9-4736-A9C9-976E430F58D4Q43122865-9E50DEBC-2E17-4083-90AB-9A9596F969DCQ44511390-0B9197E6-7C8A-4A77-9254-DB4FA5986435Q44762347-7FF2DB81-A8A8-443C-9CD1-BC2FE99D329CQ45880995-83D3CAA4-7C77-43BA-B8B0-1386909C99FDQ46169082-3A9A8863-C771-4CCA-B941-14AAFFC50522Q48001415-0DB52776-22BD-48CB-9730-9DE47CCC3857Q50978052-89CF0F7D-5260-4559-B172-77AED255DE73Q83864854-34AF81FA-6E52-49E8-AA16-283FFF575C58
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daniela Liccardo
@ast
Daniela Liccardo
@en
Daniela Liccardo
@es
Daniela Liccardo
@nl
Daniela Liccardo
@sl
type
label
Daniela Liccardo
@ast
Daniela Liccardo
@en
Daniela Liccardo
@es
Daniela Liccardo
@nl
Daniela Liccardo
@sl
prefLabel
Daniela Liccardo
@ast
Daniela Liccardo
@en
Daniela Liccardo
@es
Daniela Liccardo
@nl
Daniela Liccardo
@sl
P106
P1153
56581914900
P21
P31
P496
0000-0002-6218-1690